Investing.com -- Goldman Sachs downgraded Macy’s Inc and Torrid Holdings Inc, citing growing macroeconomic headwinds and tariff-related risks that threaten to weigh on U.S. apparel retailers.
The firm lowered its sector outlook and cut its U.S. GDP forecast for 2025 to 0.5% from 2.5%, warning of a 45% chance of recession.
While not baking in a full downturn yet, Goldman said the mix of slowing growth, geopolitical uncertainty, and rising tariffs could pressure earnings across the sector.
“We reduce our outlook for the US apparel and softlines sector to reflect a more cautious macro backdrop,” Goldman wrote, adding that higher tariffs, inventory imbalances, foreign boycotts, and weaker tourist-driven demand all present risks.
Goldman downgraded Macy’s to “Neutral” from “Buy” with a $12 price target, citing the department store’s exposure to economic cycles.
Historical data suggests department store sales consistently underperform during downturns, analysts at Goldman said.
Torrid was downgraded to “Sell” with a $4 target.
While noting recent efforts by management, Goldman said the brand is especially exposed to slower U.S. growth and had already shown signs of weakening consumer demand.
Tariff-related uncertainty remains a key overhang. Although a 90-day pause allows retailers to buy holiday products at reduced rates, Goldman said a 145% tariff on goods from China, especially in home categories, poses significant disruption.
Off-price retailers such as TJX (NYSE:TJX), Burlington (NYSE:BURL), and Ross may also face challenges, particularly in home goods sourcing.
Despite the downgrade, Goldman highlighted select names with pricing power and strong balance sheets, like TJX, Burlington, Tapestry (NYSE:TPR), and Ralph Lauren (NYSE:RL), as better positioned to weather the current volatility.
Related articles
Goldman Sachs downgrades Macy’s and Torrid on macro, tariff risks
Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy
Barclays downgrades Texas Instruments on China risk, demand concerns
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。